PGC-1 Coactivators Regulate MITF and the Tanning Response

Molecular Cell

Volumn 49, Issue 1, 2013, Pages 145-157

  Shoag, Jonathan ^a   Haq, Rizwan ^b,d   Zhang, Mingfeng ^c   Liu, Laura ^a   Rowe, Glenn C ^a   Jiang, Aihua ^a   Koulisis, Nicole ^a   Farrel, Caitlin ^a   Amos, Christopher I ^f   Wei, Qingyi ^f   Lee, Jeffrey E ^f   Zhang, Jiangwen ^e   Kupper, Thomas S ^c   Qureshi, Abrar A ^c   Cui, Rutao ^g   Han, Jiali ^c,h   Fisher, David E ^b,d,i   Arany, Zoltan ^a,i  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^e HARVARD UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PIGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER SUSCEPTIBILITY; CELL PROTECTION; CONTROLLED STUDY; GENE EXPRESSION; GENE INDUCTION; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MELANOCYTE; MELANOGENESIS; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN STABILITY; QUANTITATIVE TRAIT LOCUS; RADIATION EXPOSURE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN BIOPSY; SKIN CANCER; SKIN COLOR; SKIN PROTECTION; TRANSGENIC ANIMAL; ULTRAVIOLET RADIATION;

ALPHA-MSH; ANIMALS; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; GENE EXPRESSION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEAT-SHOCK PROTEINS; HUMANS; KERATINOCYTES; MELANINS; MELANOCYTES; MELANOMA; MICE; MICE, INBRED C57BL; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEIN STABILITY; SKIN NEOPLASMS; SUNTAN; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

ANIMALIA;

EID: 84872276087     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2012.10.027     Document Type: Article

References (61)

1. Arany Z., Foo S.-Y., Ma Y., Ruas J.L., Bommi-Reddy A., Girnun G.D., Cooper M., Laznik D., Chinsomboon J., Rangwala S.M., et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α. Nature 2008, 451:1008-1012.
2. Arany Z., Wagner B.K., Ma Y., Chinsomboon J., Laznik D., Spiegelman B.M. Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1alpha and oxidative phosphorylation. Proc. Natl. Acad. Sci. USA 2008, 105:4721-4726.
3. Baccarelli A., Landi M.T. [Risk factors of malignant skin melanoma in Italian population: review of results of a case-control study]. Epidemiol. Prev. 2002, 26:293-299.
4. Bultman S.J., Michaud E.J., Woychik R.P. Molecular characterization of the mouse agouti locus. Cell 1992, 71:1195-1204.
5. Carreira S., Goodall J., Aksan I., La Rocca S.A., Galibert M.D., Denat L., Larue L., Goding C.R. Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature 2005, 433:764-769.
6. Carreira S., Goodall J., Denat L., Rodriguez M., Nuciforo P., Hoek K.S., Testori A., Larue L., Goding C.R. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 2006, 20:3426-3439.
7. Challis B.G., Coll A.P., Yeo G.S., Pinnock S.B., Dickson S.L., Thresher R.R., Dixon J., Zahn D., Rochford J.J., White A., et al. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). Proc. Natl. Acad. Sci. USA 2004, 101:4695-4700.
8. Chang J.S., Huypens P., Zhang Y., Black C., Kralli A., Gettys T.W. Regulation of NT-PGC-1alpha subcellular localization and function by protein kinase A-dependent modulation of nuclear export by CRM1. J. Biol. Chem. 2010, 285:18039-18050.
9. Cheli Y., Giuliano S., Botton T., Rocchi S., Hofman V., Hofman P., Bahadoran P., Bertolotto C., Ballotti R. Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. Oncogene 2011, 30:2307-2318.
10. Cheli Y., Giuliano S., Fenouille N., Allegra M., Hofman V., Hofman P., Bahadoran P., Lacour J.P., Tartare-Deckert S., Bertolotto C., Ballotti R. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Oncogene 2012, 31:2461-2470.
11. Chinsomboon J., Ruas J., Gupta R.K., Thom R., Shoag J., Rowe G.C., Sawada N., Raghuram S., Arany Z. The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle. Proc. Natl. Acad. Sci. USA 2009, 106:21401-21406.
12. Cui R., Widlund H.R., Feige E., Lin J.Y., Wilensky D.L., Igras V.E., D'Orazio J., Fung C.Y., Schanbacher C.F., Granter S.R., Fisher D.E. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 2007, 128:853-864.
13. Elwood J.M., Gallagher R.P., Davison J., Hill G.B. Sunburn, suntan and the risk of cutaneous malignant melanoma-The Western Canada Melanoma Study. Br. J. Cancer 1985, 51:543-549.
14. Fisher D.E., James W.D. Indoor tanning-science, behavior, and policy. N. Engl. J. Med. 2010, 363:901-903.
15. Flanagan N., Ray A.J., Todd C., Birch-Machin M.A., Rees J.L. The relation between melanocortin 1 receptor genotype and experimentally assessed ultraviolet radiation sensitivity. J. Invest. Dermatol. 2001, 117:1314-1317.
16. Garraway L.A., Widlund H.R., Rubin M.A., Getz G., Berger A.J., Ramaswamy S., Beroukhim R., Milner D.A., Granter S.R., Du J., et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005, 436:117-122.
17. Goding C.R. Commentary. A picture of Mitf in melanoma immortality. Oncogene 2011, 30:2304-2306.
18. Handschin C., Spiegelman B.M. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev. 2006, 27:728-735.
19. Healy E., Flannagan N., Ray A., Todd C., Jackson I.J., Matthews J.N., Birch-Machin M.A., Rees J.L. Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair. Lancet 2000, 355:1072-1073.
20. Hida T., Wakamatsu K., Sviderskaya E.V., Donkin A.J., Montoliu L., Lynn Lamoreux M., Yu B., Millhauser G.L., Ito S., Barsh G.S., et al. Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: a cAMP-independent pathway. Pigment Cell Melanoma Res. 2009, 22:623-634.
21. Hoek K.S., Goding C.R. Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res. 2010, 23:746-759.
22. Huber W.E., Price E.R., Widlund H.R., Du J., Davis I.J., Wegner M., Fisher D.E. A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes. J. Biol. Chem. 2003, 278:45224-45230.
23. Jablonski N.G., Chaplin G. The evolution of human skin coloration. J. Hum. Evol. 2000, 39:57-106.
24. Jablonski N.G., Chaplin G. Colloquium paper: human skin pigmentation as an adaptation to UV radiation. Proc. Natl. Acad. Sci. USA 2010, 107(Suppl 2):8962-8968.
25. Kathiresan S., Srivastava D. Genetics of human cardiovascular disease. Cell 2012, 148:1242-1257.
26. Kawakami Y., Tsuda M., Takahashi S., Taniguchi N., Esteban C.R., Zemmyo M., Furumatsu T., Lotz M., Izpisúa Belmonte J.C., Asahara H. Transcriptional coactivator PGC-1alpha regulates chondrogenesis via association with Sox9. Proc. Natl. Acad. Sci. USA 2005, 102:2414-2419.
27. Khaled M., Levy C., Fisher D.E. Control of melanocyte differentiation by a MITF-PDE4D3 homeostatic circuit. Genes Dev. 2010, 24:2276-2281.
28. Knutti D., Kressler D., Kralli A. Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor. Proc. Natl. Acad. Sci. USA 2001, 98:9713-9718.
29. Landi M.T., Baccarelli A., Calista D., Pesatori A., Fears T., Tucker M.A., Landi G. Combined risk factors for melanoma in a Mediterranean population. Br. J. Cancer 2001, 85:1304-1310.
30. Lee J.K., Havaleshko D.M., Cho H., Weinstein J.N., Kaldjian E.P., Karpovich J., Grimshaw A., Theodorescu D. A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery. Proc. Natl. Acad. Sci. USA 2007, 104:13086-13091.
31. Levy C., Khaled M., Fisher D.E. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol. Med. 2006, 12:406-414.
32. Lin J.Y., Fisher D.E. Melanocyte biology and skin pigmentation. Nature 2007, 445:843-850.
33. Lin W.M., Baker A.C., Beroukhim R., Winckler W., Feng W., Marmion J.M., Laine E., Greulich H., Tseng H., Gates C., et al. Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res. 2008, 68:664-673.
34. Lin J., Wu P.H., Tarr P.T., Lindenberg K.S., St-Pierre J., Zhang C.Y., Mootha V.K., Jäger S., Vianna C.R., Reznick R.M., et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 2004, 119:121-135.
35. Lin J., Yang R., Tarr P.T., Wu P.H., Handschin C., Li S., Yang W., Pei L., Uldry M., Tontonoz P., et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 2005, 120:261-273.
36. Liu F., Fu Y., Meyskens F.L. MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1. J. Invest. Dermatol. 2009, 129:422-431.
37. McGill G.G., Horstmann M., Widlund H.R., Du J., Motyckova G., Nishimura E.K., Lin Y.L., Ramaswamy S., Avery W., Ding H.F., et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 2002, 109:707-718.
38. Miller A.J., Du J., Rowan S., Hershey C.L., Widlund H.R., Fisher D.E. Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma. Cancer Res. 2004, 64:509-516.
39. Miura S., Kai Y., Kamei Y., Ezaki O. Isoform-specific increases in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to beta2-adrenergic receptor activation and exercise. Endocrinology 2008, 149:4527-4533.
40. Nan H., Kraft P., Qureshi A.A., Guo Q., Chen C., Hankinson S.E., Hu F.B., Thomas G., Hoover R.N., Chanock S., et al. Genome-wide association study of tanning phenotype in a population of European ancestry. J. Invest. Dermatol. 2009, 129:2250-2257.
41. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92:829-839.
42. Puigserver P., Rhee J., Lin J., Wu Z., Yoon J.C., Zhang C.Y., Krauss S., Mootha V.K., Lowell B.B., Spiegelman B.M. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol. Cell 2001, 8:971-982.
43. Rowe G.C., Jiang A., Arany Z. PGC-1 coactivators in cardiac development and disease. Circ. Res. 2010, 107:825-838.
44. Saha B., Singh S.K., Sarkar C., Bera R., Ratha J., Tobin D.J., Bhadra R. Activation of the Mitf promoter by lipid-stimulated activation of p38-stress signalling to CREB. Pigment Cell Res. 2006, 19:595-605.
45. Salti G.I., Manougian T., Farolan M., Shilkaitis A., Majumdar D., Das Gupta T.K. Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma. Cancer Res. 2000, 60:5012-5016.
46. Selzer E., Wacheck V., Lucas T., Heere-Ress E., Wu M., Weilbaecher K.N., Schlegel W., Valent P., Wrba F., Pehamberger H., et al. The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma. Cancer Res. 2002, 62:2098-2103.
47. St-Pierre J., Lin J., Krauss S., Tarr P.T., Yang R., Newgard C.B., Spiegelman B.M. Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J. Biol. Chem. 2003, 278:26597-26603.
48. St-Pierre J., Drori S., Uldry M., Silvaggi J.M., Rhee J., Jäger S., Handschin C., Zheng K., Lin J., Yang W., et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006, 127:397-408.
49. Strub T., Giuliano S., Ye T., Bonet C., Keime C., Kobi D., Le Gras S., Cormont M., Ballotti R., Bertolotto C., Davidson I. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene 2011, 30:2319-2332.
50. Sturm R.A. Skin colour and skin cancer - MC1R, the genetic link. Melanoma Res. 2002, 12:405-416.
51. Talantov D., Mazumder A., Yu J.X., Briggs T., Jiang Y., Backus J., Atkins D., Wang Y. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin. Cancer Res. 2005, 11:7234-7242.
52. Teslovich T.M., Musunuru K., Smith A.V., Edmondson A.C., Stylianou I.M., Koseki M., Pirruccello J.P., Ripatti S., Chasman D.I., Willer C.J., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713.
53. Trausch-Azar J., Leone T.C., Kelly D.P., Schwartz A.L. Ubiquitin proteasome-dependent degradation of the transcriptional coactivator PGC-1alpha via the N-terminal pathway. J. Biol. Chem. 2010, 285:40192-40200.
54. Tuma R.S. Reactive oxygen species may have antitumor activity in metastatic melanoma. J. Natl. Cancer Inst. 2008, 100:11-12.
55. Vats D., Mukundan L., Odegaard J.I., Zhang L., Smith K.L., Morel C.R., Wagner R.A., Greaves D.R., Murray P.J., Chawla A. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab. 2006, 4:13-24.
56. Wittgen H.G., van Kempen L.C. Reactive oxygen species in melanoma and its therapeutic implications. Melanoma Res. 2007, 17:400-409.
57. Wolfrum C., Stoffel M. Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion. Cell Metab. 2006, 3:99-110.
58. Wong T.H., Jackson I.J., Rees J.L. The physiological and phenotypic determinants of human tanning measured as change in skin colour following a single dose of ultraviolet B radiation. Exp. Dermatol. 2010, 19:667-673.
59. Wu Z., Boss O. Targeting PGC-1 alpha to control energy homeostasis. Expert Opin. Ther. Targets 2007, 11:1329-1338.
60. Yaswen L., Diehl N., Brennan M.B., Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med. 1999, 5:1066-1070.
61. Yoon J.C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., Adelmant G., Stafford J., Kahn C.R., Granner D.K., et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413:131-138.